Expedited and facilitated drug evaluations and evidence of benefit and risk: The cup is half-full
- PMID: 29871505
- DOI: 10.1177/1740774518771347
Expedited and facilitated drug evaluations and evidence of benefit and risk: The cup is half-full
Comment in
-
The US Food and Drug Administration's expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation.Clin Trials. 2018 Jun;15(3):243-246. doi: 10.1177/1740774518770657. Clin Trials. 2018. PMID: 29871507 No abstract available.
Comment on
-
The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements.Clin Trials. 2018 Jun;15(3):219-229. doi: 10.1177/1740774518770648. Clin Trials. 2018. PMID: 29871509
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources